Profil Financier
Yu De-Chao occupe actuellement le rang #3123 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.2 B (+$191 sur 24h).
Yu De-Chao, also known as Michael Yu, is the chairman and CEO of Innovent Biologics, a China-headquartered biotech company.
Innovent went public at the Hong Kong Stock Exchange in 2018.
Yu holds a PhD in molecular genetics from the Chinese Academy of Sciences.
Yu had a postdoc position in pharmaceutical chemistry at the University of California San Francisco from 1993 to 1996.